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Background/aim: To determine the frequency of migraine in the eastern part of Turkey and its sociodemographic characteristics,
impact on disability, and clinical aspects.
Materials and methods: The study was conducted door-to-door in the eastern part of Turkey. Those who suffered from headaches were
diagnosed with migraine as per the 2004 diagnosis criteria of the International Headache Society and its frequency was determined.
Demographic data and Migraine Disability Assessment Scale (MIDAS) scores were recorded.
Results: Of the individuals evaluated, 60.4% (883) suffered from headaches, of which 43.6% (637) were evaluated as nonmigraine and
16.8% (246) as migraine headaches. Migraine prevalence was detected to be 10.3% (75) in men and 23.1% (171) in women. When the
MIDAS scale was considered, 7.3% of the patients were classified with mild pain, 36.9% with mild to moderate pain, 41% with moderate
pain, and 14.6% with severe pain.
Conclusion: Migraine headache has a wide and complex range of symptoms and is frequently observed in women and young adults. The
prevalence of migraine among the general population of eastern Turkey was found to be similar to the averages in the rest of the country,
as well to the averages of studies in Europe.
Key words: Migraine, prevalence, disability, sociodemographic properties

1. Introduction
Migraine is a significant public health issue in regard to
its impact on both the individual’s life and on the public.
Migraine negatively affects society and impacts quality of
life. Many studies have been conducted about the incidence
of migraine, with significant differences obtained from the
prevalence data. Prevalence changes according to age, with
studies indicating a peak between the ages of 20 and 40 years
old. Lifetime prevalence is 10% in men and 25% in women
(1–3). Headache diagnosis criteria were established by the
International Headache Society (IHS) in 2004 (4).
Despite the fact that many tools have been developed
to evaluate disability, one of the most widely used scales for
this purpose is the Migraine Disability Assessment Scale
(MIDAS) (5). The ratio of the cases in which migraine
leads to average and severe levels of functionality loss have
been found not to be relative to sex, age, income, urban/
rural settlement, or region of residence (6).
In this study, we aimed to determine the level of
prevalence, clinical aspects of migraine headache,
demographic particulars of the cases, and the loss of workactivity resulting from the disease.
* Correspondence: recepdemirnoroloji@hotmail.com
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2. Materials and methods
This study was performed within the Atatürk University
Medical Faculty in eastern Turkey. In headache
epidemiology studies conducted in Turkey, the migraine
prevalence was previously based on the 18- to 55-year-old
age group, and it was calculated that any study needs to be
performed on 527 people in order to reach a confidence
interval of 99%. In our study, the number of people required
to be reached in relation to the general population of the
city was determined from data provided by every family
physician department located within the bounds of the
city. For the physicians participating in this study, training
was provided by lecturers experienced in the headache
field in order to ensure standardization of the headache
diagnoses. In total, 6 physicians were commissioned for
the study. This study was performed by door-to-door
house visits and face-to-face interviews.
In our study, a systematic sampling method was used.
The province was split into quarters as a starting point,
and, through a random draw, the right side and number 4
were selected. Starting from each quarter of the area, the
survey was conducted by advancing on the right side of the
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fourth street beginning with the fourth building. Before
the interview, the purpose of the study was explained
to each person on an individual basis, and the survey
was completed by the individuals who volunteered to
participate in the study.
The study was performed in 2 phases. In the first
phase, a preliminary scan form was applied and a total of
1461 individuals were evaluated. On the preliminary scan
form, sociodemographic particulars (age, marital status,
educational status, economic status, past medical history,
occupation) were determined and those who suffered
from headaches were identified.
In the second phase, for the cases meeting the IHS
migraine diagnosis criteria using a standardized survey
form related to headache, the clinical aspects of the
headaches were determined. The interview questions
included the following: frequency of headaches;
characteristics and features; relation to menstruation;
level of intensity; existence of an aura accompanying the
headache (complaints or symptoms); timing of the aura,
its duration, and characteristics; presence of nausea,
vomiting; sensitivity to light, sound, or odor; loss of
appetite; impact on physical activities; the location of the
pain; the time of day that onset occurs; factors that stop or
trigger the headache; sleeping routine; and if follow-up or
treatment was being sought.
In order to determine the decreased efficiency in home
and work life of those patients experiencing migraine
attacks, and the restrictions on their normal activities,
the MIDAS survey was applied, the validity of which is
proven in Turkish society. The MIDAS survey consists of 5
questions, and the first, third, and fifth determine the days
lost at school, work, and home or during spare time over the
previous 3 months. The second and the fourth questions
evaluate the number of additional days where there was
a loss of efficiency due to migraines, where efficiency is
identified as a decrease by at least 50% compared to the
previous 3 months. There were 2 additional questions —
“How many days did you have a headache during the last
3 months?” and “What is the average intensity of your
headaches on a scale between 0 and 10?” — that evaluated
the frequency and the intensity of the headaches but were
not added to the total MIDAS value. The MIDAS score was
obtained by adding the scores of the first 5 questions. From
this, the MIDAS restriction degree was calculated. A score
between 0 and 5 represented degree I (no restrictions or
very low); a score between 6 and 10 represented degree
II (moderate or few restrictions), a score between 11 and
20 represented degree III (average level of restriction);
and a score of 21 or higher represented degree IV (heavy
restrictions).

2.1. Statistical evaluation
Statistical evaluations were done using SPSS 20.0 (SPSS
Inc., Chicago, IL, USA). The comparison of the data was
done by chi-square test. Statistical hypotheses were tested
using P < 0.05 as the level of statistical significance.
3. Results
Of the people taking part in the study, 60.4% (883) suffered
from headaches. Of these, 43.6% (637) were evaluated as
nonmigraine headaches. According to the IHS diagnosis
criteria, without discriminating by sex, 246 (16.8%) of
the patients were diagnosed with migraine. Migraine was
detected in 171 women (23.1%) and 75 men (10.3%).
Furthermore, 69.5% of those with migraines were women
and 30.5% were men. The ratio of women to men was 2.3.
The migraine frequency between the sexes was statistically
meaningful (Table 1).			
After the age of 40, there was an apparent decrease in
the frequency of migraine. It was most frequently observed
among the group aged 30–39 (35.3%) (Figure 1). Aura was
present in 30% (74) of the migraine cases, and 70% (172)
were without aura (Figure 2). Phonophobia was identified
as one of the frequent symptoms accompanying migraine
headache (91.5%). While problems with bright light
(15.9%) and moderate (19.5%) and intense (17.1%) levels
of nausea were observed, nausea was not present in 47.6%
of the patients. Photophobia was identified in 76.8% of
the patients, sensitivity to odor was determined in 52.4%,
and vomiting was found in 29.3%. It was determined that
physical activity during the attack made the headache
worse for 67.1% and did not have any impact for 32.9% of
the migraine sufferers.
The headache was detected to be pulsating in 216
individuals (87.8%) and had other characteristics in 18
individuals (12.2%).
In 58.5% of the cases, the headache was one-sided,
and in 41.5% it was diffused. A slight to moderate level
of headache was found in 24.4% of the cases, and 35.4%
suffered an intense headache. In 40.2% of the cases,
the intensity of the headache caused function loss and
presented a necessity for bed rest. The frequency of the
attacks was once or less than once a month in 20% of the
migraine cases, between 1 and 4 times per month in 38%,
and 4 or more times in 42% of the cases.
Among the triggering factors, the most frequent cause
identified was emotional stress (85.4%). Other triggers
included noise (69.5%), irregular sleep (67.9%), bright light
(45.9%), hunger and skipping meals (38.6%), heat (33.7%),
and smoking (31.7%). In women with migraine, migraine
attacks were worse during menstruation (Table 2).
In this study, it was found that 12.2% of the patients
had not been taking medications during the attacks and
74.4% were using analgesics. Among the latter group,
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Table 1. Distribution of sociodemographic characteristic frequencies and percentages as per the sex of patients with migraine.
Total (%)

Women (%)

Men (%)

Number of the individuals participating in the study (%)

1461 (100%)

738 (50.5%)

723 (49.5%)

Average age of the participants of the study (years)

36.5 ± 14.45

35.8 ± 13.9

37.3 ± 14.9

Number of patients with headache

883 (60.4%)

544 (73.1%)

339 (46.9%)

Number of patients with migraine

246 (16.8%)

171 (23.1%)

75 (10.3%)

Number of patients with nonmigraine headache

637 (43.6%)

373 (50.5%)

264 (36.5%)

Average age of those with migraine (years)

35.87 ± 11.9

34.5 ± 11.1

39.8 ± 13.4

Number of migraine cases with aura

74 (5.1%)

55 (7.4%)

19 (2.6%)

Number of migraine cases without aura

172 (11.8%)

116 (15.7%)

56 (7.7%)

Education (%)
1. None
2. Primary school
3. Secondary school
4. High school
5. Higher education

24 (9.8%)
78 (31.7%)
27 (11.0%)
51 (20.7%)
66 (26.8%)

20 (11.7%)
64 (37.4%)
17 (9.9%)
37 (21.6%)
33 (19.2%)

4 (5.3%)
14 (18.6%)
10 (13.3%)
14 (18.6%)
33 (44.0%)

<0.0001

Economic status
1. Low
2. Medium
3. Good or high

180 (73.1%)
57 (23.1%)
9 (3.7%)

124 (72.5%)
43 (25.1%)
4 (2.3%)

56 (74.6%)
14 (18.7%)
5 (6.7%)

<0.0001

Age intervals (years)
1. Between ages of 15 and 29
2. Between ages of 30 and 39
3. Between ages of 40 and 49
4. Age 50 or over

79 (31.7%)
87 (35.3%)
38 (15.8%)
42 (17.1%)

58 (33.9%)
69 (40.3%)
22 (12.8%)
22 (12.8%)

21 (28.0%)
18 (24.0%)
16 (21.3%)
20 (26.6%)

0.015

Occupation
1. Housewife
2. Student
3. Employee
4. Other

114 (46.3%)
24 (9.8%)
66 (26.9%)
42 (17.0%)

114 (66.7%)
14 (8.2%)
20 (11.7%)
23 (13.5%)

10 (13.3%)
46 (61.3%)
19 (25.4%)

<0.0001

Family history of migraine
1. Present
2. None

106 (43.1%)
140 (56.9%)

79 (46.2%)
92 (53.8%)

27 (36.0%)
48 (64.0%)

<0.0001

73.2% expressed that the medications were effective. We
found that 45.1% of the migraine patients had previously
seen a neurological specialist and 11% of these patients
also saw other specialists, while 7.3% had seen a practicing
physician and 36.6% had not consulted with any physicians.
Generally, in the MIDAS survey evaluation, 37.8%
scored degree I, 20.7% scored degree II, 23.2% scored
degree III, and 18.3% scored degree IV. When we consider
the MIDAS headache intensity detection scale, 7.3% of
the patients expressed that their headaches had been at
level 4 or lower. The headache intensity was detected to
be between 5 and 6 for 36.9% of the patients, 7 and 8 for
41% of the patients, and 9 and 10 for 14.6% of the patients
according to the MIDAS visual analog scale (Table 3).
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P

<0.0001

0.010

4. Discussion
In our study, the frequency of migraine in individuals
of 18 years of age or older living in the east of Turkey was
determined as 16.8%. In men the percentage was 10.3% and
in women the percentage was 23.1%. Of those patients with
migraine, 69.5% were women and 30.5% were men. Migraine
prevalence studies generally suggest that the frequency
among the population is 3%–28%, with the prevalence
in women at 4%–33% and in men at 2%–22% (2,7). In the
multicenter Headache Epidemiology Study in Turkey, the
migraine prevalence was 16.4% between the ages of 15 and
55 without discriminating between sexes, with 21.8% of the
women and 10.9% of the men reported to be suffering from
migraines. On a regional basis, in addition to the fact that
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Migraine with aura
Migraine without aura

Prevalence , %
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Figure 1. Age groups.

females

males

Figure 2. Prevalence of migraine types.

Table 2. Migraine frequency and percentage distributions associated with precipitation factors.
Precipitation factors

General
(%)

Without aura
(%)

With aura
(%)

P ≤ 0.05

Mental tension and stress

85.4

83.7

89.2

<0.0001

Sleep disorder

67.9

70.3

62.2

<0.0001

Noise

69.5

66.9

75.7

<0.0001

Hunger

38.6

41.9

31.1

<0.0001

Bright light

45.9

48.3

40.5

<0.0001

Menstruation

36.6

35.3

40.0

<0.0001

Weather changes (hot-cold)

33.7

34.3

32.4

<0.0001

Cigarette

31.7

35.5

25.7

<0.0001

the prevalence changes to 11.4%–14.7% in the Marmara,
Central Anatolia, and Black Sea regions, this value reaches
20.6%–24% in the Aegean, Mediterranean, East Anatolia, and
Southeast Anatolia regions (8). We obtained results similar
to the average of Turkey as a whole. However, according to
the data for the southeastern region alone, we had a lower
detection rate in eastern Turkey (16.8% against 24%).
Boru et al. (7) detected migraine prevalence as 15.8%
in women between the ages of 15 and 45 having fertility capability and living in İstanbul. Çelik et al. (9) reported the
general prevalence of migraine over the age of 14 as 19.9%,
and as 9.3% in men and 29.3% in women. Migraine preva-

lence was reported to be 14.7% in a sample of more than
170,000 adult individuals (8% in men, 17.6% in women)
(10). In another study, prevalence was reported between
6% and 8% in men and between 12% and 14% in women
(11). Global migraine prevalence was determined as 15%,
with 10% in men and 22% in women. Regionally, the prevalence was found to be 9% in Africa, 15% in Australia, 13%
in Europe, and 9% in North America (12). According to
our studies, in addition to reporting a similar frequency,
we see a higher prevalence in women. These differences
may be caused by cultural, climatic, and geographic differences between Thrace and eastern Anatolia.
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Table 3. MIDAS scores of migraine patients and some general characteristics.
MIDAS scores

General (%)

Women (%)

Men (%)

P ≤ 0.05

37.8%
20.7%
23.2%
18.3%

36.8%
15.8%
26.3%
21.1%

40.0%
32.0%
16.0%
12.0%

<0.0001

12.2%
74.4%
13.4%

12.3%
71.9%
15.8%

12.0%
80.0%
8.0%

<0.0001

Visit to a physician by the individual
1. No visit
2. Practitioner physician
3. Neurology specialist
4. Other specialist physicians

36.6%
7.3%
45.1%
11.0%

33.3%
7.0%
49.1%
10.5%

44.0%
8.0%
36.0%
12.0%

<0.0001

Effectiveness of the attack medication
1. Effective
2. Ineffective

73.2%
26.8%

70.2%
29.8%

0.0%
20.0%

1.
2.
3.
4.

Degree I (0–5)
Degree II (6–10)
Degree III (11–20)
Degree IV (≥21 and higher)

Attack medication administered by the individual
1.
2.
3.

No medication
Pain killers
Other medications

The possible reasons why migraine increases in women
after the first menstruation is that migraine is related to
menstruation, the impacts caused by the use of birth
control medications, and the effects of changes in the sex
hormones of women (13).
Steiner et al. (14) found the highest prevalence in the
age group of 30–39 years (25.9%) and lowest in those aged
60 and older (12.1%). Lipton et al. (15) detected the values
as 18.6% for the 30–39 age group and 19.0% for the group
aged between 40 and 49. However, Rasmussen et al. (16)
reported that the prevalence does not change between
different age groups. In our study, when the frequency of
migraine was evaluated per age group, it was detected to
be highest for those aged between 30 and 39 (35.3%) and
lowest for those over 50 (17.1%).
In studies performed in Turkey, it is seen that migraine
prevalence is high among housewives and higher education
graduates (17). Aygul et al. (18), in their hospital-based
migraine study performed in Erzurum, detected the ratio of
men to women as 1:3.2, and more than half of the women
were housewives (61.4%). At the same time, 70.8% were
married. The majority of the patients (75.7%) suffered
from intense headache attacks. Most (79.5%) had low or
average income levels and half had graduated after 11 years
of school education. In our study, attention was drawn to
the fact that migraines were most frequent in housewives
(46.3%), and in men they were more prevalent in those who
were graduates of higher education (44%). A reasonable
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<0.0001

explanation for this is the greater health awareness among
higher education graduates who, therefore, may have been
attending related polyclinics at a higher rate.
Migraine is a disease with a high family prevalence,
representing a genetic predisposition. Patients with migraine who presented with a past family history range
between 45% and 70% (19). In our studies, a past history
of migraine in first-degree family members was found to
have a high correlation at 43.1%.
In the Headache Epidemiology Study of Turkey, during
1 year, it is estimated that the labor lost due to migraine is
approximately 5.4 days (7). According to the MIDAS, Boru
et al. reported 44.5% of migraine cases as degree I, 37.3%
as degree II, 11.7% as degree III, and only 6.5% as degree
IV (7). In our study, 93 individuals (37.8%) were detected
at MIDAS degree I, 51 individuals (20.7%) at MIDAS degree II, 57 (23.2%) at MIDAS degree III, and 45 individuals
(18.3%) at MIDAS degree IV. Even though there are differences between the results, migraine causes labor loss by
leading to significant restrictions and economic burdens.
In our study, migraine headache prevalence in the
eastern Anatolian region was low when compared to the
averages in Turkey but was similar to those in Europe.
In conclusion, migraine is the most frequent primary
episodic headache disease. Migraine is more frequent
among women, among those who have low economic
levels, and among graduates of higher education. The majority of migraine patients have a past migraine history in
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their first-degree relatives. Migraine causes labor loss leading to significant restrictions, introduces economic losses,

and may significantly decrease the productivity of individuals by causing disturbances in life quality.
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